NIBBIO, Gabriele
 Distribuzione geografica
Continente #
NA - Nord America 2.378
AS - Asia 2.038
EU - Europa 1.401
SA - Sud America 494
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 53
Totale 6.450
Nazione #
US - Stati Uniti d'America 2.258
SG - Singapore 800
IT - Italia 591
CN - Cina 485
BR - Brasile 418
HK - Hong Kong 221
DE - Germania 194
VN - Vietnam 154
BD - Bangladesh 150
FR - Francia 97
FI - Finlandia 94
GB - Regno Unito 88
RU - Federazione Russa 71
TR - Turchia 63
CA - Canada 62
UA - Ucraina 46
IN - India 38
MX - Messico 34
CZ - Repubblica Ceca 33
PL - Polonia 30
NL - Olanda 28
AR - Argentina 23
AT - Austria 23
IE - Irlanda 21
SE - Svezia 21
ZA - Sudafrica 21
ID - Indonesia 18
IQ - Iraq 18
JP - Giappone 18
EC - Ecuador 14
PY - Paraguay 13
ES - Italia 12
PK - Pakistan 10
SA - Arabia Saudita 9
AL - Albania 8
CO - Colombia 8
UZ - Uzbekistan 8
LT - Lituania 7
MA - Marocco 7
PT - Portogallo 7
CR - Costa Rica 6
NP - Nepal 6
EG - Egitto 5
PE - Perù 5
PH - Filippine 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
BG - Bulgaria 4
ET - Etiopia 4
IL - Israele 4
PA - Panama 4
VE - Venezuela 4
AO - Angola 3
CL - Cile 3
DZ - Algeria 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
NO - Norvegia 3
PS - Palestinian Territory 3
RO - Romania 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LV - Lettonia 2
OM - Oman 2
RS - Serbia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GR - Grecia 1
HN - Honduras 1
IM - Isola di Man 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
ML - Mali 1
NI - Nicaragua 1
PR - Porto Rico 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 6.365
Città #
Singapore 409
Ashburn 287
Hong Kong 221
San Jose 204
New York 131
Beijing 112
Milan 107
The Dalles 103
Los Angeles 102
Munich 96
Council Bluffs 78
Brescia 73
Helsinki 70
Lauterbourg 60
Columbus 58
Fairfield 57
Chandler 55
Boardman 54
Ho Chi Minh City 50
Istanbul 49
Chicago 40
São Paulo 40
Dallas 35
Princeton 34
Santa Clara 33
Seattle 31
Hanoi 30
Moscow 30
Redondo Beach 29
Shanghai 28
Buffalo 27
Warsaw 27
Woodbridge 27
Cambridge 26
Houston 26
Jacksonville 25
Orem 25
San Francisco 24
Wilmington 24
Brno 23
Frankfurt am Main 23
Dublin 21
London 21
Rome 21
Romola 19
Turku 18
Toronto 17
Atlanta 15
Brooklyn 15
Des Moines 15
Düsseldorf 15
Turin 15
Ann Arbor 14
Montreal 14
Nuremberg 14
Palazzolo sull'Oglio 14
Phoenix 14
Stockholm 14
Tokyo 14
Amsterdam 13
Mexico City 13
Naples 12
Denver 11
Haiphong 11
Manchester 11
Belo Horizonte 10
Charlotte 10
Johannesburg 10
Porto Alegre 10
Ankara 9
Guangzhou 9
Olomouc 9
Changsha 8
Dearborn 8
Nanjing 8
New Delhi 8
Padua 8
Paris 8
San Diego 8
Tashkent 8
Venice 8
Verona 8
Campinas 7
Jakarta 7
Poplar 7
Rio de Janeiro 7
Asunción 6
Bergamo 6
Boston 6
Curitiba 6
Guayaquil 6
Hangzhou 6
Jinan 6
Lappeenranta 6
Palermo 6
Querétaro 6
Vienna 6
Brasília 5
Chennai 5
Clifton 5
Totale 3.600
Nome #
Adult ADHD: Prevalence and Clinical Correlates in a Sample of Italian Psychiatric Outpatients 200
Autistic symptoms predict social cognitive performance in patients with schizophrenia 172
Autistic Symptoms in Schizophrenia: Impact on Internalized Stigma, Well-Being, Clinical and Functional Characteristics 162
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia: A Systematic Review and Meta-analysis of Randomized Clinical Trials 150
Cognitive impairment after recovery from COVID-19: Frequency, profile, and relationships with clinical and laboratory indices 149
Adult ADHD and sleep disorders: Prevalence, severity and predictors of sleep disorders in a sample of Italian psychiatric outpatients 146
Impact of Physical Exercise Alone or in Combination with Cognitive Remediation on Cognitive Functions in People with Schizophrenia: A Qualitative Critical Review 139
Evidence-Based Integrated Intervention in Patients with Schizophrenia: A Pilot Study of Feasibility and Effectiveness in a Real-World Rehabilitation Setting 132
Acceptability of cognitive remediation for schizophrenia: A systematic review and meta-analysis of randomized controlled trials 127
The Elephant in the Room: A Cross-Sectional Study on the Stressful Psychological Effects of the COVID-19 Pandemic in Mental Healthcare Workers 125
Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial 124
Psychological impact of Covid-19 pandemic in mental healthcare workers: a cross-sectional study in an Italian Department of Mental Health 124
Cognitive and clinical characteristics of offenders and non-offenders diagnosed with schizophrenia spectrum disorders: results of the Recoviwel observational study 121
Current Evidence and Theories in Understanding the Relationship between Cognition and Depression in Childhood and Adolescence: A Narrative Review 121
Efficacy and tolerability of Brain Stimulation interventions in Borderline Personality Disorder: state of the art and future perspectives – A systematic review 121
Social Cognition in a Research Domain Criteria Perspective: A Bridge Between Schizophrenia and Autism Spectra Disorders 118
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 117
Autistic Symptoms and Social Cognition Predict Real-World Outcomes in Patients With Schizophrenia 116
Application of cognitive remediation in the world: new experiences from two schizophrenia rehabilitation centers in Togo and Benin 114
Life engagement in people living with schizophrenia: predictors and correlates of patient life engagement in a large sample of people living in the community 110
Implementation of cognitive rehabilitation interventions for schizophrenia in low-income countries: An experience from Togo and Benin 110
Paliperidone extended-release in the short- and long-term treatment of schizophrenia 109
Effects of bilateral, bipolar-nonbalanced, frontal transcranial Direct Current Stimulation (tDCS) on negative symptoms and neurocognition in a sample of patients living with schizophrenia: Results of a randomized double-blind sham-controlled trial 108
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 102
Personality traits and disorders among adult ADHD Patients: Is borderline personality disorder as common as we expect? 100
The economic burden of schizophrenia spectrum disorders: clinical and functional correlates and predictors of direct costs. A retrospective longitudinal study 100
Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study 98
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study 96
Autistic symptoms in people with schizophrenia: Neurocognitive, socio-cognitive, clinical and real-world functional characteristics of individuals without autistic features 96
Assessment and correlates of autistic symptoms in Schizophrenia Spectrum Disorders measured with the PANSS Autism Severity Score: A systematic review 94
The Relationship between Cognitive Impairment and Violent Behavior in People Living with Schizophrenia Spectrum Disorders: A Critical Review and Treatment Considerations 94
Internalized stigma among people with schizophrenia: Relationship with socio-demographic, clinical and medication-related features 94
Schizophrenia during the COVID-19 pandemic 91
Blood homocysteine concentration and mood disorders with mixed features among patients with alcohol use disorder 87
Long-acting Injectable Antipsychotics during the COVID-19 pandemic in schizophrenia: An observational study in a real-world clinical setting 87
European Psychiatric Association guidance on treatment of cognitive impairment in schizophrenia 85
Shared and distinct abnormalities in sleep-wake patterns and their relationship with the negative symptoms of Schizophrenia Spectrum Disorder patients 85
Verso la medicina di precisione in psichiatria: validazione clinica di un approccio farmacogenomico combinato nel trattamento del Disturbo Depressivo Maggiore 84
Conceptualization and characterization of "primary" and "secondary" cognitive impairment in schizophrenia 83
Is It Possible to Combine Non-Invasive Brain Stimulation and Evidence-Based Psychosocial Interventions in Schizophrenia? A Critical Review 82
Treatment of Cognitive Impairment Associated with Schizophrenia Spectrum Disorders: New Evidence, Challenges, and Future Perspectives 82
What impact can brain stimulation interventions have on borderline personality disorder? 79
The interplay between childhood trauma, hopelessness, depressive symptoms, and mental pain in a large sample of patients with severe mental disorders: A network analysis 79
The influence of autistic symptoms on social and non-social cognition and on real-life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study 79
Paliperidone palmitate in short- and long-term treatment of schizophrenia 78
Well-Being and Mental Health: Where Do We Stand After COVID-19 Pandemic? 75
Patient-reported outcomes in the clinical management of depression: current status and future directions 75
Predictors of psychosocial functioning in people diagnosed with schizophrenia spectrum disorders that committed violent offences and in those that did not: Results of the Recoviwel study 73
Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses 71
Efficacy of Functional Remediation on Cognitive and Psychosocial Functioning in Patients with Bipolar Disorder: Study Protocol for a Randomized Controlled Study 71
Does pharmacogenetic testing optimise antidepressant effectiveness in major depressive disorder? Data from a double blind randomized controlled trial in a real-world setting 70
Non-pharmacological interventions to improve cognitive impairment and psychosocial functioning in schizophrenia: a critical review 69
Evidence-based psychosocial interventions in schizophrenia: A critical review 69
Socio-demographic and clinical characteristics of SARS-CoV-2-positive psychiatric in-patients: A case-control study in the psychiatric wards of a Great Metropolitan Hospital in Milan 69
Effectiveness and Safety of Bright Light Therapy in Oncological Patients: A Systematic Review 64
The role of pharmacogenetics in the treatment of major depressive disorder: a critical review 62
Editorial: Case reports in schizophrenia and psychotic disorders 61
Gender Differences in Anxiety and Depression before and after Alcohol Detoxification: Anxiety and Depression as Gender-Related Predictors of Relapse 59
Insulin-resistance as a modifiable pathway to cognitive dysfunction in schizophrenia: A systematic review 57
Editorial: Methods and applications in psychopathology: new methods and trends for the understanding of neuropsychiatric disorders 55
Prevalence of cocaine use and cocaine use disorder among adult patients with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis 55
Pharmacological Treatment of Cognitive Impairment Associated With Schizophrenia: State of the Art and Future Perspectives 54
Editorial: Case reports in Schizophrenia and psychotic disorders: 2023 52
Editorial: Cognitive and mental health improvement under- and post-COVID-19, volume III 51
Treatment of Comorbid Adult Attention-deficit/Hyperactivity Disorder and Generalized Anxiety Disorder: 2 Case Reports 46
MCMI-III Personality Disorders, Traits, and Profiles in Adult ADHD Outpatients 46
Editorial: Cognitive and mental health improvement under- and post-COVID-19 44
Reply to: “Letter to the Editor: Cocaine use and cocaine use disorder - Revisiting epidemiology and clinical impact” 41
Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch 27
Mild motor signs in major depressive disorder: prevalence and clinical profile 24
Cognitive Impairment Associated with Schizophrenia: insights and treatment perspectives 12
Artificial Intelligence in Schizophrenia Spectrum Disorders: Current Use and Future Perspectives. A Systematic Mapping Literature Review 11
tDCS effects on life engagement in schizophrenia: results from a double-blind sham-controlled trial 10
Artificial intelligence applications in mental health: the state of the art 7
Totale 6.450
Categoria #
all - tutte 33.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.748


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022124 0 19 8 7 5 6 4 10 7 15 6 37
2022/2023236 21 2 0 13 14 46 20 35 42 7 21 15
2023/2024559 21 15 50 41 32 87 25 12 71 28 4 173
2024/20251.424 26 29 39 165 147 110 129 70 193 134 216 166
2025/20263.469 338 396 252 528 343 229 410 163 203 273 212 122
2026/2027336 197 139 0 0 0 0 0 0 0 0 0 0
Totale 6.450